24 results
6-K
EX-10.1
PRTG
Portage Biotech Inc
3 Oct 23
Current report (foreign)
4:05pm
are qualified by materiality or Material Adverse Effect, in all respects) when made and on the Closing Date of the representations and warranties … material respects (or, to the extent representations or warranties are qualified by materiality or Material Adverse Effect, in all respects
6-K
EX-5.2
PRTG
Portage Biotech Inc
3 Oct 23
Current report (foreign)
4:05pm
, conscionability and materiality (regardless of whether the Securities are considered in a proceeding in equity or at law), including, without limitation
6-K
EX-10.3
PRTG
Portage Biotech Inc
8 Jul 22
Current report (foreign)
8:58am
respects (except to the extent that any of such representations and warranties is already qualified as to materiality in Section 4 above, in which case … as to materiality in Section 4 of the Purchase Agreement, in which case, such representations and warranties are true and correct without further
6-K
EX-2.1
i3j8sh ykyp1
8 Jul 22
Current report (foreign)
8:58am
20-F/A
n4v5c
3 Mar 22
Annual report (foreign) (amended)
6:57pm
6-K
EX-99.1
kpjqb r26c2mmadnju
3 Mar 20
Consolidated Interim Financial Statements
12:00am
6-K
EX-99.1
xx10e
19 Feb 19
Report of Foreign Private Issuer
10:37am
6-K
mtilbocf
6 Jul 12
Amended and Restated Settlement Agreement June 29, 2012
12:00am
424B3
vb2 uv95b9o9nbo80zib
9 Jan 12
Prospectus supplement
12:00am
424B3
hdc7brlwp8ujb
9 Jan 12
Prospectus supplement
12:00am
6-K
i2k 5h2tr
6 Jan 12
Settlement Agreement
12:00am